RVLP logo

RVL Pharmaceuticals (RVLP) Cash From Investing

RVLP Annual CFI

$126.00 K
-$116.33 M-99.89%

31 December 2022

RVLP Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RVLP Quarterly CFI

-$959.00 K
+$266.00 K+21.71%

30 June 2023

RVLP Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RVLP TTM CFI

-$2.13 M
-$1.02 M-91.61%

30 June 2023

RVLP TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RVLP Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-99.9%-1782.5%-101.9%
3 y3 years+103.1%-30.6%+41.1%
5 y5 years+100.7%-28.8%+47.1%

RVLP Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-99.9%-100.9%-101.8%

RVL Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
June 2023
-
-$959.00 K(-21.7%)
-$2.13 M(+91.6%)
Mar 2023
-
-$1.23 M(+612.2%)
-$1.11 M(-980.2%)
Dec 2022
$126.00 K(-99.9%)
-$172.00 K(-174.5%)
$126.00 K(-43.5%)
Sept 2022
-
$231.00 K(+305.3%)
$223.00 K(-99.8%)
June 2022
-
$57.00 K(+470.0%)
$110.59 M(+0.9%)
Mar 2022
-
$10.00 K(-113.3%)
$109.58 M(-5.9%)
Dec 2021
$116.45 M(-3876.0%)
-$75.00 K(-100.1%)
$116.45 M(+0.6%)
Sept 2021
-
$110.60 M(<-9900.0%)
$115.82 M(+2460.6%)
June 2021
-
-$954.00 K(-113.9%)
$4.52 M(-4.6%)
Mar 2021
-
$6.88 M(-1066.4%)
$4.74 M(-253.8%)
Dec 2020
-$3.08 M
-$712.00 K(+2.9%)
-$3.08 M(-7.3%)
Sept 2020
-
-$692.00 K(-5.7%)
-$3.33 M(-7.8%)
DateAnnualQuarterlyTTM
June 2020
-
-$734.00 K(-22.4%)
-$3.61 M(-16.7%)
Mar 2020
-
-$946.00 K(-1.0%)
-$4.33 M(+7.7%)
Dec 2019
-$4.02 M(-2.8%)
-$956.00 K(-1.7%)
-$4.02 M(-4.5%)
Sept 2019
-
-$973.00 K(-33.2%)
-$4.21 M(+4.1%)
June 2019
-
-$1.46 M(+129.3%)
-$4.04 M(+21.4%)
Mar 2019
-
-$635.00 K(-44.6%)
-$3.33 M(-19.4%)
Dec 2018
-$4.13 M(-78.7%)
-$1.15 M(+42.0%)
-$4.13 M(+38.4%)
Sept 2018
-
-$806.80 K(+8.4%)
-$2.99 M(+37.0%)
June 2018
-
-$744.50 K(-48.2%)
-$2.18 M(+51.8%)
Mar 2018
-
-$1.44 M
-$1.44 M
Dec 2017
-$19.40 M(-95.7%)
-
-
Dec 2016
-$453.46 M
-
-

FAQ

  • What is RVL Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for RVL Pharmaceuticals?
  • What is RVL Pharmaceuticals annual CFI year-on-year change?
  • What is RVL Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for RVL Pharmaceuticals?
  • What is RVL Pharmaceuticals quarterly CFI year-on-year change?
  • What is RVL Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for RVL Pharmaceuticals?
  • What is RVL Pharmaceuticals TTM CFI year-on-year change?

What is RVL Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of RVLP is $126.00 K

What is the all time high annual CFI for RVL Pharmaceuticals?

RVL Pharmaceuticals all-time high annual cash flow from investing activities is $116.45 M

What is RVL Pharmaceuticals annual CFI year-on-year change?

Over the past year, RVLP annual cash flow from investing activities has changed by -$116.33 M (-99.89%)

What is RVL Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of RVLP is -$959.00 K

What is the all time high quarterly CFI for RVL Pharmaceuticals?

RVL Pharmaceuticals all-time high quarterly cash flow from investing activities is $110.60 M

What is RVL Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, RVLP quarterly cash flow from investing activities has changed by -$1.02 M (-1782.46%)

What is RVL Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of RVLP is -$2.13 M

What is the all time high TTM CFI for RVL Pharmaceuticals?

RVL Pharmaceuticals all-time high TTM cash flow from investing activities is $116.45 M

What is RVL Pharmaceuticals TTM CFI year-on-year change?

Over the past year, RVLP TTM cash flow from investing activities has changed by -$112.72 M (-101.92%)